Cyclo Therapeutics, Inc. (CYTHW) Financials

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$0
Day's range
$0
$5M$5M$0$0-$5M-$5M-$10M-$10M-$15M-$15M-$20M-$20M-$25M-$25MEarning201720172018201820192019202020202021202120222022202320231000%1000%500%500%0%0%-500%-500%-1000%-1000%-1500%-1500%-2000%-2000%Profit Margin
Profit Margin
Revenue
Earnings

CYTHW Income statement / Annual

Last year (2023), Cyclo Therapeutics, Inc.'s total revenue was $1.08 M, a decrease of 21.76% from the previous year. In 2023, Cyclo Therapeutics, Inc.'s net income was -$20.06 M. See Cyclo Therapeutics, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Operating Revenue $1.08 M $1.38 M $1.59 M $903.38 K $1.01 M $1.01 M $1.24 M $1.50 M $950.46 K $1.57 M
Cost of Revenue $98.46 K $138.93 K $156.08 K $66.40 K $75.49 K $105.03 K $132.92 K $198.43 K $124.43 K $272.64 K
Gross Profit $977.95 K $1.24 M $1.43 M $836.98 K $931.71 K $906.45 K $1.10 M $1.30 M $826.03 K $1.29 M
Gross Profit Ratio 0.91 0.9 0.9 0.93 0.93 0.9 0.89 0.87 0.87 0.83
Research and Development Expenses $14.18 M $9.00 M $9.15 M $6.10 M $4.87 M $2.71 M $2.29 M $1.86 M $658.51 K $94.13 K
General & Administrative Expenses $5.66 M $7.81 M $6.50 M $3.68 M $3.43 M $2.43 M $2.62 M $2.64 M $2.22 M $1.53 M
Selling & Marketing Expenses $3.90 K $13.06 K $18.34 K $5.01 K $5.89 K $5.64 K $7.85 K $7.16 K $7.57 K $10.90 K
Selling, General & Administrative Expenses $6.83 M $7.82 M $6.52 M $3.68 M $3.44 M $2.44 M $2.63 M $2.65 M $2.23 M $1.55 M
Other Expenses $0.00 $30.50 K $27.54 K $19.95 K $13.98 K $13.95 K $19.77 K $130.95 K $202.02 K $217.52 K
Operating Expenses $21.04 M $16.85 M $15.70 M $9.80 M $8.32 M $5.16 M $4.95 M $4.65 M $3.09 M $1.86 M
Cost And Expenses $21.13 M $16.99 M $15.85 M $9.86 M $8.40 M $5.27 M $5.08 M $4.85 M $3.22 M $2.13 M
Interest Income $0.00 $12.47 K $3.41 K $19.80 K $12.03 K $0.00 $0.00 $0.00 $0.00 $0.00
Interest Expense $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $28.60 K $31.29 K $33.67 K
Depreciation & Amortization $19.28 K $19.48 K $16.83 K $12.76 K $5.68 K $10.12 K $9.27 K $107.10 K $169.03 K $152.45 K
EBITDA -$20.03 M -$15.60 M -$14.27 M -$8.95 M -$7.39 M -$4.24 M -$3.82 M -$4.09 M -$2.23 M -$406.57 K
EBITDA Ratio -18.61 -11.34 -9 -9.91 -7.33 -4.2 -3.09 -2.72 -2.35 -0.26
Operating Income Ratio -18.63 -11.35 -9 -9.92 -7.34 -4.22 -3.11 -2.8 -2.53 -0.36
Total Other Income/Expenses Net -$7.25 K $171.00 K $3.41 K $19.80 K $12.03 K $11.77 K $10.26 K -$17.95 K -$24.62 K -$30.37 K
Income Before Tax -$20.06 M -$15.45 M -$14.29 M -$8.94 M -$7.53 M -$4.26 M -$3.83 M -$4.22 M -$2.43 M -$592.69 K
Income Before Tax Ratio -18.63 -11.23 -9.01 -9.9 -7.48 -4.21 -3.1 -2.81 -2.56 -0.38
Income Tax Expense $0.00 -$171.00 K $18.52 K -$18.53 K $141.75 K $11.77 K $0.00 $28.60 K $120.00 K $33.67 K
Net Income -$20.06 M -$15.28 M -$14.31 M -$8.92 M -$7.67 M -$4.26 M -$3.83 M -$4.22 M -$2.55 M -$592.69 K
Net Income Ratio -18.63 -11.11 -9.02 -9.88 -7.62 -4.21 -3.1 -2.81 -2.68 -0.38
EPS -1.23 -1.81 -2.25 -5.58 -7.09 -5.2 -5.32 -6.67 -4.54 -1.17
EPS Diluted -1.23 -1.81 -2.25 -5.58 -7.09 -5.2 -5.32 -6.67 -4.54 -1.17
Weighted Average Shares Out $16.33 M $8.44 M $6.37 M $1.60 M $1.08 M $817.57 K $720.37 K $633.54 K $562.09 K $505.43 K
Weighted Average Shares Out Diluted $16.33 M $8.44 M $6.37 M $1.60 M $1.08 M $817.57 K $720.37 K $633.54 K $562.09 K $505.43 K
Link